Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Cited by (687)

Items 201–300 of 687

1. Thermodynamic Features of Structural Motifs Formed by β-L-RNA
   Marta Szabat, Dorota Gudanis, Weronika Kotkowiak, Zofia Gdaniec, Ryszard Kierzek, Anna Pasternak · 2016 · PLoS ONE
2. Advances in Mechanochemical Methods for One‐Pot Multistep Organic Synthesis
   Nina Biedermann, Michael Schnürch · 2025 · Chemistry - A European Journal
3. Oligonucleotide-Based Therapies for Renal Diseases
   Fernando Cartón‐García, Cassondra J Saande, Daniel Meraviglia-Crivelli, Rafael Aldabe, Fernando Pastor · 2021 · Biomedicines
4. Site-Specific Scissors Based on Myeloperoxidase for Phosphorothioate DNA
   Zhian Hu, Jinlei Yang, Fujian Xu, Gongwei Sun, Xingyu Pan, Meng-Chan Xia, Sichun Zhang, Xinrong Zhang · 2021 · Journal of the American Chemical Society
5. Therapeutic Oligonucleotides with Polyethylene Glycol Modifications
   Johannes Winkler · 2015 · Future Medicinal Chemistry
6. Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair
   Guoling Li, Xiaohui Yang, Xinxin Luo, Zhenfang Wu, Huaqiang Yang · 2023 · Cell & Bioscience
7. Synthesis, Biophysical and Biological Evaluation of Splice-Switching Oligonucleotides with Multiple LNA-Phosphothiotriester Backbones
   Debashis Dhara, Alyssa C. Hill, Abinaya Ramesh, Matthew J. A. Wood, Afaf Helmy El-Sagheer, Tom P Brown · 2024 · Journal of the American Chemical Society
8. Chemical strategies for antisense antibiotics
   Mathijs J. Pals, Alexander Lindberg, Willem A. Velema · 2024 · Chemical Society Reviews
9. The Yin and Yang of nucleic acid-based therapy in the brain
   Stefano Gustincich, Silvia Zucchelli, Antonello Mallamaci · 2016 · Progress in Neurobiology
10. An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability
    Atsushi Irie, Kazuki Sato, Hiroya Kuwahara, Takeshi Wada, Futoshi Shibasaki · 2020 · Scientific Reports
11. Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment
    Lorenzo Arrico, Carmine Stolfi, Irene Marafini, Giovanni Monteleone, Salvatore Demartis, Salvatore Bellinvia, Francesca Viti, Marie McNulty, Irene Cabani, Anita Falezza et al. · 2022 · Nucleic Acid Therapeutics
12. The XNA alphabet
    John Charles Chaput, Martin Egli, Piet A. Herdewijn · 2025 · Nucleic Acids Research
13. Mechanochemical Synthesis of Short DNA Fragments
    James D. Thorpe, Daniel O’Reilly, Tomislav Friščić, Masad José Damha · 2020 · Chemistry - A European Journal
14. Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease
    Marc Suñé-Pou, María José Limeres, Cristina Moreno‐Castro, Cristina Hernández-Munaín, Josep Maria Suñé-Negre, María L. Cuestas, Carlos Suñé · 2020 · Frontiers in Genetics
15. Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
    Maria Ester Gagliardi, Ana Tari Ashizawa · 2022 · Pharmaceutics
16. Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment
    Valentin Feichtenschlager, Yixuan James Zheng, Wilson Wai-Shing Ho, Li-Nan Chen, Ciara Callanan, Christopher Chen, Albert Lee, Jose Ortiz, Klemens Rappersberger, Susana Ortiz‐Urda · 2023 · Oncotarget
17. Efficient Conjugation to Phosphorothioate Oligonucleotides by Cu-Catalyzed Huisgen 1,3-Dipolar Cycloaddition
    Małgorzata Honcharenko, Dmytro Honcharenko, Roger Strömberg · 2019 · Bioconjugate Chemistry
18. Manufacturing of Oligonucleotides
    E. Paredes, Vincent Aduda, Kathryn L. Ackley, H. Cramer · 2017 · Elsevier eBooks
19. Single-molecule optical mapping of the distribution of DNA phosphorothioate epigenetics
    Yue Wei, Qinqin Huang, Xihao Tian, Mingmin Zhang, Junkai He, Xingxiang Chen, Chao Chen, Zixin Deng, Zhiqiang Li, Shi Chen et al. · 2021 · Nucleic Acids Research
20. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for In Vivo Imaging
    Lin Zhang, Lingli Zhou, Hui Zhang, Yibin Zhang, Ling Li, Tiantian Xie, Yinglei Chen, Xiaodong Li, Neng Ling, Jing Dai et al. · 2021 · ACS Applied Materials & Interfaces
21. The functional coupling between restriction and DNA phosphorothioate modification systems underlying the DndFGH restriction complex
    Dan Wu, Yaqian Tang, Siwei Chen, Yue He, Xiaofei Chang, Wenzhong Zheng, Zixin Deng, Zhiqiang Li, Lianrong Wang, Geng Wu et al. · 2022 · Nature Catalysis
22. Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1
    Jessica Stoodley, Francisco Vallejo-Bedia, David Seoane-Miraz, Manuel Debasa‐Mouce, Matthew J. A. Wood, Miguel A. Varela · 2023 · International Journal of Molecular Sciences
23. Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers
    Romesh R. Subramanian, Mark Wysk, Kathleen M. Ogilvie, Abhijit Bhat, Bing Kuang, Thomas Dino Rockel, Markus Weber, Eugen Uhlmann, Arthur Μ. Krieg · 2015 · Nucleic Acids Research
24. Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
    Shipra Malik, Raman Bahal · 2019 · Journal of Nanobiotechnology
25. A palindromic-based strategy for colorimetric detection of HIV-1 nucleic acid: Single-component assembly of gold nanoparticle-core spherical nucleic acids
    Abbas Karami, Masoumeh Hasani · 2019 · Analytica Chimica Acta
26. RNA therapies for CNS diseases
    Valentina Di Francesco, Andy Jian Kai Chua, Di Huang, Anisha A. D’souza, Alicia Yang, Benjamin Saul Bleier, Mansoor M. Amiji · 2024 · Advanced Drug Delivery Reviews
27. Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant HTT
    Naoki Iwamoto, Yuanjing Liu, Maria D. Frank-Kamenetsky, Abbie Maguire, Wei Chou Tseng, Kristin Taborn, Nayantara Kothari, Akhtar Ali, Keith Bowman, Juili Dilip Shelke et al. · 2024 · Molecular Therapy — Nucleic Acids
28. Advances in the Application of Modified Nucleotides in SELEX Technology
    Olga M. Antipova, Elena G. Zavyalova, Andrey V. Golovin, Galina Valerievna Pavlova, Alexey M. Kopylov, Roman V. Reshetnikov · 2018 · Biochemistry (Moscow)
29. Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
    Saskia Breuel, Mariann Vorm, Anja Ursula Bräuer, Marta Owczarek‐Lipska, John Neidhardt · 2019 · Molecular Therapy — Nucleic Acids
30. Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability
    Ander Maguregui, Hiroshi Abe · 2020 · ChemBioChem
31. Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
    Vito Genna, Javier Iglesias‐Fernández, Laura Reyes-Fraile, Núria Villegas, Kevin M. Guckian, Punit P. Seth, Brad Wan, Cristina Cabrero, Montserrat Terrazas, Isabelle Brun Heath et al. · 2023 · Nucleic Acids Research
32. In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3′ and 5′ thiophosphate linkages
    Jörg Duschmalé, Henrik Frydenlund Hansen, Martina Duschmalé, Erich Koller, Nanna Albæk, Marianne Ravn Møller, Klaus Jensen, Troels Koch, Jesper Wengel, Konrad Bleicher · 2019 · Nucleic Acids Research
33. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
    Tushar Singh Barwal, Uttam Sharma, Sonali Bazala, Ipsa Singh, Manju Jain, Hridayesh Prakash, Shashank Shekhar, Elise N. Sandberg, Anupam Bishayee, Aklank Jain · 2021 · International Journal of Molecular Sciences
34. Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo
    Ting Li, Fengjiao Yao, Yacong An, Xundou Li, Jinhong Duan, Xian‐Da Yang · 2021 · Molecules
35. From polymerase engineering to semi-synthetic life: artificial expansion of the central dogma
    Leping Sun, Xingyun Ma, Binliang Zhang, Yanjia Qin, Jiezhao Ma, Yuhui Du, Tingjian Chen · 2022 · RSC Chemical Biology
36. Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage
    Ann-Jay Tong, Rebecca A. Leylek, Anna‐Maria Herzner, Diamanda Rigas, Sara M. Wichner, Craig Blanchette, Siri Tähtinen, Christopher C. Kemball, Ira Mellman, Benjamin Haley et al. · 2023 · The Journal of Experimental Medicine
37. Mirror-Image DNA Nanobox for Enhancing Environment Resistance of Nucleic Acid Probes
    Shiquan Li, Yihao Liu, Minze He, Yani Yang, Shuoyao He, Haolan Hu, Mengyi Xiong, Yifan Lyu · 2024 · ACS Nano
38. Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the Liver
    Aaron Joseph Donner, Edward V. Wancewicz, Heather M. Murray, Sarah Greenlee, Noah M. Post, Melanie Bell, Walt F. Lima, Eric E. Swayze, Punit P. Seth · 2017 · Nucleic Acid Therapeutics
39. 5′ capped and 3′ polyA-tailed sgRNAs enhance the efficiency of CRISPR-Cas9 system
    Wei Mu, Yongping Zhang, Xutong Xue, Lei Liu, Xiaofei Wei, Haoyi Wang · 2018 · Protein & Cell
40. DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer
    Geoffrey Casas, Federico Perche, Patrick Midoux, Chantal Pichon, Jean‐Marc Malinge · 2022 · Molecular Therapy — Nucleic Acids
41. Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
    Jenny Lange, Haiyan Zhou, Amy McTague · 2022 · Frontiers in Molecular Neuroscience
42. Interfering with nucleotide excision by the coronavirus 3′-to-5′ exoribonuclease
    Rukesh Chinthapatla, Mohamad S. Sotoudegan, Pankaj K. Srivastava, Thomas K. Anderson, Ibrahim M. Moustafa, Kellan T. Passow, Samantha A. Kennelly, Ramkumar Moorthy, David Dulin, Joy Y. Feng et al. · 2022 · Nucleic Acids Research
43. Next steps for the optimization of exon therapy for Duchenne muscular dystrophy
    Galina E. Filonova, Annemieke M Aartsma-Rus · 2023 · Expert Opinion on Biological Therapy
44. RNA nanostructures for targeted drug delivery and imaging
    Laura Teodori, Marjan Omer, Jørgen Kjems · 2024 · RNA Biology
45. Mercury-Free Automated Synthesis of Guanidinium Backbone Oligonucleotides
    Kacper Skakuj, Katherine E. Bujold, Chad Alexander Mirkin · 2019 · Journal of the American Chemical Society
46. Enhanced affinity of racemic phosphorothioate DNA with transcription factor SATB1 arising from diastereomer-specific hydrogen bonds and hydrophobic contacts
    Kazuhiko Yamasaki, Yukie Akutsu, Tomoko Yamasaki, Makoto Miyagishi, Tomomi Kubota · 2020 · Nucleic Acids Research
47. Why and How to Control P-Chirality in Phosphorothioated Therapeutic Oligonucleotides: Analytical Challenges Associated with Determination of Stereochemical Composition
    Tanja Poredoš, Marko Trampuž, Tjaša Gornik, Klemen Naveršnik, Maša Sinreih, Samo Pirc, Zdenko Časar · 2024 · Organic Process Research & Development
48. RNA Structure: Past, Future, and Gene Therapy Applications
    William A. Haseltine, Kim Hazel, Roberto Patarca · 2024 · International Journal of Molecular Sciences
49. Stereoselective synthesis of P-stereogenic nucleotide prodrugs and oligonucleotides
    Jia-Bao Wang, Jie Lv, Siddheshwar Kisan Bankar, Shuai-Shuai Fang, Ming Shang · 2025 · Chemical Society Reviews
50. Wavelength-Selective Activation of Photocaged DNAzymes for Metal Ion Sensing in Live Cells
    Xiao Gang Xu, Lu Xiao, Chunmei Gu, Jiachen Shang, Yu Xiang · 2021 · ACS Omega
51. Computer Aided Development of Nucleic Acid Applications in Nanotechnologies
    Markéta Paloncýová, Martin Pykal, Petra Kührová, Pavel Banáš, Jiřı́ Šponer, Michal Otyepka · 2022 · Small
52. Antisense Therapy for Infectious Diseases
    Lwanda Abonga Buthelezi, Shandre Pillay, Noxolo Ntuli, Lorna Gcanga, Reto Guler · 2023 · Cells
53. Late-stage guanine C8–H alkylation of nucleosides, nucleotides, and oligonucleotides via photo-mediated Minisci reaction
    Ruoqian Xie, Wan‐Lu Li, Yuhua Ge, Yutong Zhou, Guolan Xiao, Qin Zhao, Yunxi Han, Yangyan Li, Gang Chen · 2024 · Nature Communications
54. Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor
    Hans J. Gaus, Colton M. Miller, Punit P. Seth, Edward N. Harris · 2018 · Biochemistry
55. Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges
    Ruchi Ruchi, Govind Mukesh Raman, Vikas Kumar, Raman Bahal · 2024 · Expert Opinion on Drug Discovery
56. Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
    Kaili Ou, Qingqing Jia, Dandan Li, Shihua Li, Xiao‐Jiang Li, Peng Yin · 2025 · Translational Neurodegeneration
57. Short-interference RNAs: becoming medicines
    Tamara Martı́nez, Jiménez, Ana Isabel, Covadonga Pañeda · 2015 · EXCLI journal
58. Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
    Jonathan Hall · 2023 · RNA
59. Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery
    Luca Volpini, Federica Monaco, Lory Santarelli, Jiřı́ Neužil, Marco Tomasetti · 2023 · Aspects of Molecular Medicine
60. Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity
    Hassan H. Fakih, Qi Tang, Ashley Summers, Minwook Shin, Julianna E. Buchwald, Rosemary Gagnon, Vignesh Narayan Hariharan, Dimas Echeverria, David Cooper, Jonathan K. Watts et al. · 2023 · Molecular Therapy — Nucleic Acids
61. Separation of the diastereomers of phosphorothioated siRNAs by anion-exchange chromatography under non-denaturing conditions
    Hiroyuki Togawa, Takashi Okubo, Kazuki Horiuchi, Takao Yamaguchi, Elisa Tomita‐Sudo, Tomoka Akita, Junji Kawakami, Satoshi Obika · 2024 · Journal of Chromatography A
62. Impact of ion-pairing systems choice on diastereomeric selectivity of phosphorothioated oligonucleotides in reversed-phase liquid chromatography
    Zuzana Kadlecová, Martin Gilár, Květa Kalíková · 2024 · Journal of Chromatography A
63. The Chemistry of the Noncanonical Cyclic Dinucleotide 2′3′-cGAMP and Its Analogs
    Frank Schwede, Hans‐Gottfried Genieser, Andreas Rentsch · 2015 · Handbook of experimental pharmacology
64. Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
    Oleg V. Markov, Anton V. Filatov, Maxim S. Kupryushkin, Ivan V. Chernikov, Olga Patutina, Anton A. Strunov, Elena L. Chernolovskaya, Valentin V. Vlassov, Dmitrii V. Pyshnyi, Зенкова Марина Аркадьевна · 2020 · Molecules
65. Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency
    Derek M. Erion, Leah Y. Liu, Christopher R. Brown, Stephen I. Rennard, Humam Farah · 2024 · CHEST Journal
66. DNA Phosphorothioate Modification Systems and Associated Phage Defense Systems
    Lianrong Wang, Yaqian Tang, Zixin Deng, Shi Chen · 2024 · Annual Review of Microbiology
67. Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats
    F. Romero-Palomo, Matthias Festag, Barbara F. Lenz, Simone Schadt, Andreas Brink, Anja Kipar, Bernd Steinhuber, Christophe Husser, Erich Koller, Sabine Sewing et al. · 2021 · Toxicologic Pathology
68. Structurally constrained phosphonate internucleotide linkage impacts oligonucleotide-enzyme interaction, and modulates siRNA activity and allele specificity
    Ken Yamada, Samuel R. Hildebrand, Sarah M. Davis, Rachael Miller, Faith Conroy, Ellen Sapp, Jillian Caiazzi, Julia F. Alterman, Loïc Roux, Dimas Echeverria et al. · 2021 · Nucleic Acids Research
69. Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers
    Si‐ping Han, Lisa J. Scherer, Matt Gethers, Ane Miren Salvador, Marwa Ben Haj Salah, Rebecca A. Mancusi, Sahil Sagar, Robin Hu, Julia M. DeRogatis, Ya‐Huei Kuo et al. · 2022 · Molecular Therapy — Nucleic Acids
70. Thermophilic Nucleic Acid Polymerases and Their Application in Xenobiology
    Guangyuan Wang, Yuhui Du, Xingyun Ma, Fangkai Ye, Yanjia Qin, Yangming Wang, Yuming Xiang, Rui Xin Tao, Tingjian Chen · 2022 · International Journal of Molecular Sciences
71. Recent advances in the molecular design and applications of viral RNA-targeting antiviral modalities
    Jiaojiao Dai, Xiangyi Jiang, Edeildo Ferreira da Silva‐Júnior, Shaoqing Du, Xinyong Liu, Peng Zhan · 2024 · Drug Discovery Today
72. Application of Nucleic Acid Frameworks in the Construction of Nanostructures and Cascade Biocatalysts: Recent Progress and Perspective
    Gan Zhu, Ping Song, Jing Wu, Minglan Luo, Zhipeng Chen, Tingjian Chen · 2022 · Frontiers in Bioengineering and Biotechnology
73. Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2
    Vaishnavi Srinivasan Iyer, Sanjaykumar V. Boddul, Anna‐Karin Johnsson, Bruno Raposo, Ravi Kumar Sharma, Yunbing Shen, Zsolt Kasza, Kah Wai Lim, Karine Chemin, Gunnar P. Nilsson et al. · 2022 · Journal of Autoimmunity
74. Towards Self-Transfecting Nucleic Acid Nanostructures for Gene Regulation
    Saketh Gudipati, Ke Zhang, Jessica L. Rouge · 2019 · Trends in biotechnology
75. Integration of chemically modified nucleotides with DNA strand displacement reactions for applications in living systems
    Adam M. Kabza, Nandini Kundu, Wenrui Zhong, Jonathan T. Sczepanski · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
76. Structures of annexin A2-PS DNA complexes show dominance of hydrophobic interactions in phosphorothioate binding
    Malwina Hyjek‐Składanowska, Brooke A. Anderson, Vitaliy B. Mykhaylyk, Christian M. Orr, Armin Wagner, Jarosław T. Poznański, Krzysztof J. Skowronek, Punit P. Seth, Marcin Nowotny · 2022 · Nucleic Acids Research
77. Nicking mechanism underlying the DNA phosphorothioate-sensing antiphage defense by SspE
    Haiyan Gao, Xinqi Gong, Jinchuan Zhou, Yubing Zhang, Jinsong Duan, Yue Wei, Liuqing Chen, Zixin Deng, Jiawei Wang, Shi Chen et al. · 2022 · Nature Communications
78. Antisense oligonucleotide is a promising intervention for liver diseases
    Kailing Lu, Qijing Fan, Xiaoju Zou · 2022 · Frontiers in Pharmacology
79. Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides
    Liujuan Zhou, Jie Bi, Shenghai Chang, Zhaoshuai Bai, Junqi Yu, Ruru Wang, Zhihang Li, Xing Zhang, James Jeiwen Chou, Liqiang Pan · 2024 · Angewandte Chemie International Edition
80. Inflammatory bowel disease: new therapies from antisense oligonucleotides
    Irene Marafini, Giovanni Monteleone · 2018 · Annals of Medicine
81. Oligonucleotide modifications enhance probe stability for single cell transcriptome in vivo analysis (TIVA)
    Sean B. Yeldell, Brittani K. Ruble, Ivan J. Dmochowski · 2017 · Organic & Biomolecular Chemistry
82. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
    Jelka Pohar, Duško Lainšček, Ana Kunšek, Miša Mojca Cajnko, Roman Jerala, Mojca Benčina · 2017 · Scientific Reports
83. RNA-Targeting Techniques: A Comparative Analysis of Modern Approaches for RNA Manipulation in Cancer Research and Therapeutics
    Michaela A. Boti, Marios A. Diamantopoulos, Andreas Scorilas · 2025 · Genes
84. Altered Biodistribution and Hepatic Safety Profile of a Gapmer Antisense Oligonucleotide Bearing Guanidine-Bridged Nucleic Acids
    Takashi Sasaki, Yoko Hirakawa, Fumiko Yamairi, Takashi Kurita, Karin Murahashi, Hirokazu Nishimura, Norihiko Iwazaki, Hidenori Yasuhara, Takashi Tateoka, Tetsuya Ohta et al. · 2022 · Nucleic Acid Therapeutics
85. Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review
    Zorica Nakevska, Toshifumi Yokota · 2023 · European Journal of Cell Biology
86. Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
    Sarah Engelbeen, Daniel O’Reilly, Davy van de Vijver, Ingrid E.C. Verhaart, Maaike van Putten, Vignesh Narayan Hariharan, Matthew R. Hassler, Anastasia Khvorova, Masad José Damha, Annemieke M Aartsma-Rus · 2023 · Nucleic Acid Therapeutics
87. Photocascade chemoselective controlling of ambident thio(seleno)cyanates with alkenes via catalyst modulation
    Injamam Ul Hoque, Apurba Samanta, Shyamal Pramanik, Soumyadeep Roy Chowdhury, Rabindranath Lo, Soumitra Maity · 2024 · Nature Communications
88. Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
    Daniel B. Engelhardt, Peter Nordberg, Laurent Knerr, Lara R. Malins · 2024 · Angewandte Chemie International Edition
89. Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
    Anne Sadewasser, Erik Dietzel, Sven Michel, Michael Klüver, Markus Helfer, Tamara Thelemann, Richard Klar, Markus Eickmann, Stephan Becker, Frank Jaschinski · 2019 · Molecular Therapy — Nucleic Acids
90. Stereospecific Effects of Oxygen‐to‐Sulfur Substitution in DNA Phosphate on Ion Pair Dynamics and Protein–DNA Affinity
    Dan Nguyen, Levani Zandarashvili, Mark Andrew White, Junji Iwahara · 2016 · ChemBioChem
91. Development of a detection method for antisense oligonucleotides in mouse kidneys by matrix‐assisted laser desorption/ionization imaging mass spectrometry
    Hiroyuki Yokoi, Yuya Kasahara, Satoshi Obika, Takefumi Doi, Haruhiko Kamada · 2018 · Rapid Communications in Mass Spectrometry
92. Detection of phosphorothioated (PS) oligonucleotides in horse plasma using a product ion (m/z 94.9362) derived from the PS moiety for doping control
    Teruaki Tozaki, Kaoru Karasawa, Yohei Minamijima, Hideaki Ishii, Mio Kikuchi, Hironaga Kakoi, Kei-ichi HIROTA, Kanichi Kusano, Shun-ichi NAGATA · 2018 · BMC Research Notes
93. The cGAS-STING signaling pathway is modulated by urolithin A
    Helena Borland Madsen, Jae Hyeon Park, X. Chu, Yujun Hou, Zaiwang Li, Lene Juel Rasmussen, Deborah L. Croteau, Vilhelm A. Bohr, Mansour Akbari · 2023 · Mechanisms of Ageing and Development
94. Buffer optimization of siRNA-lipid nanoparticles mitigates lipid oxidation and RNA-lipid adduct formation
    Daniel A. Estabrook, Lihua Huang, Olivia R. Lucchese, Dylan J. Charland, Yu Rong Zhao, Fareed Bhasha Sayyed, Jonas Y. Buser, Younghoon Oh, Xingyan Liu, Harmon A. Johnson et al. · 2025 · Nature Communications
95. Cationic Micelles Outperform Linear Polymers for Delivery of Antisense Oligonucleotides in Serum: An Exploration of Polymer Architecture, Cationic Moieties, and Cell Addition Order
    Mckenna G. Hanson, Christian J. Grimme, Cristiam F. Santa Chalarca, Theresa M. Reineke · 2022 · Bioconjugate Chemistry
96. Influence of Combinations of Lipophilic and Phosphate Backbone Modifications on Cellular Uptake of Modified Oligonucleotides
    Timofey D. Zharkov, Oleg V. Markov, Sergey A. Zhukov, Svetlana N. Khodyreva, Maxim S. Kupryushkin · 2024 · Molecules
97. Gene therapy for ultrarare diseases: a geneticist’s perspective
    Wuh‐Liang Hwu · 2024 · Journal of Biomedical Science
98. Structural Studies and Gene Silencing Activity of siRNAs Containing Cationic Phosphoramidate Linkages
    Danielle Vlaho, Johans F. Fakhoury, Masad José Damha · 2017 · Nucleic Acid Therapeutics
99. The Medicinal Chemistry of RNase H-activating Antisense Oligonucleotides
    Punit P. Seth, Eric E. Swayze · 2019 · Royal Society of Chemistry eBooks
100. Solid-Phase Synthesis of Phosphate/Boranophosphate Chimeric DNAs Using the H-Phosphonate–H-Boranophosphonate Method
     Kazuki Sato, Hiroki IMAI, Tomohito Shuto, Hiroya Kuwahara, Takeshi Wada · 2019 · The Journal of Organic Chemistry